Form 4 for COR Cencora
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-12 · accession 0001127602-21-029229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-15 | 2021-11-12+ | COR | Clark Gina | EVP | M - OptEx | $98.24 | +18.9K | 31.3K | +154% | +$1.86M |
| D | 2021-11-15 | 2021-11-12 | COR | Clark Gina | EVP | A - Grant | — | +14.5K | 49.7K | +41% | — |
| DM | 2021-11-15 | 2021-11-12+ | COR | Clark Gina | EVP | F - Tax | $120.58 | -6,607 | 44.4K | -13% | -$796.6K |
| D | 2021-11-15 | 2021-11-12 | COR | Clark Gina | EVP | S - Sale+OE | $125.83 | -16.0K | 28.4K | -36% | -$2.02M |
| DM | 2021-11-15 | 2021-11-12+ | COR | Clark Gina | EVP | M - OptEx | $0.00 | -18.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-12 | M | A | 16,027 | $98.24 | 35,218 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-12 | A | A | 14,512 | — | 49,730 | D | — | — | (F1) Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. |
| 3 | Common | Common Stock | 2021-11-14 | F | D | 1,262 | $125.34 | 29,998 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-12 | S | D | 16,027 | $125.83 | 28,358 | D | — | — | |
| 5 | Common | Common Stock | 2021-11-14 | M | A | 2,902 | — | 31,260 | D | — | — | (F2) Grant of restricted stock units received on November 14, 2018 for no consideration and vested 100% on the third anniversary of the date of grant. |
| 6 | Common | Common Stock | 2021-11-12 | F | D | 5,345 | $119.45 | 44,385 | D | — | — | |
| 7 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-11-12 | M | D | 16,027 | $0.00 | 0 | D | $98.24 · — to 2022-11-11 | 16,027 Common Stock | (F3) Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19. |
| 8 | Derivative | Restricted Stock Units | 2021-11-14 | M | D | 2,902 | — | 0 | D | — · — to — | 2,902 Common Stock | (F2) Grant of restricted stock units received on November 14, 2018 for no consideration and vested 100% on the third anniversary of the date of grant. |